PLIANT THERAPEUTICS, INC. Contracts & Agreements
28 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (3)
- Human Resources (9)
- Real Estate (2)
- Uncategorized (7)
- Amended and Restated Loan and Security Agreement, by and among the Registrant, the lenders from time to time party thereto and Oxford Finance LLC, dated March 11, 2024 (Filed With SEC on May 6, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 27, 2024)
- Termination Agreement by and between Healthpeak OP, LLC and the Company, dated September 28, 2023 (Filed With SEC on October 3, 2023)
- Lease Agreement by and between HCP BTC, LLC and the Company, dated September 28, 2023 (Filed With SEC on October 3, 2023)
- Underwriting Agreement, dated as of January 24, 2023, by and among Pliant Therapeutics, Inc. and J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the... (Filed With SEC on January 25, 2023)
- Underwriting Agreement, dated as of July 12, 2022, by and among Pliant Therapeutics, Inc. and J.P. Morgan Securities LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on July 14, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2022)
- Description of the Registrants Securities (Filed With SEC on March 16, 2021)
- Offer Letter, by and between the Registrant and Mike Ouimette, dated August 17, 2020 (Filed With SEC on November 10, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 26, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on May 26, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on May 26, 2020)
- 2020 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on May 26, 2020)
- Specimen Common Stock Certificate of the Registrant (Filed With SEC on May 26, 2020)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 19, 2019 (Filed With SEC on May 11, 2020)
- Collaboration and License Agreement, by and between the Registrant and Novartis Institutes For Biomedical Research, Inc., dated October 17, 2019 (Filed With SEC on May 11, 2020)
- Office Lease, by and between the Registrant and 260 Littlefield Avenue South San Francisco, California 94080, dated February 6, 2018 (Filed With SEC on May 11, 2020)
- Form of Indemnification Agreement, by and between the Registrant and each of its directors and certain officers (Filed With SEC on May 11, 2020)
- Offer Letter, by and between the Registrant and Barbara Howes, dated May 1, 2019 (Filed With SEC on May 11, 2020)
- Offer Letter, by and between the Registrant and ric Lefebvre, M.D., dated February 28, 2018 (Filed With SEC on May 11, 2020)
- Offer Letter, by and between the Registrant and Keith Cummings, M.D., MBA, dated November 29, 2018 (Filed With SEC on May 11, 2020)
- Offer Letter, by and between the Registrant and Hans Hull, J.D., dated February 10, 2016 (Filed With SEC on May 11, 2020)
- Offer Letter, by and between the Registrant and Bernard Coulie, M.D., Ph.D., dated October 12, 2015 (Filed With SEC on May 11, 2020)
- Executive Severance Plan (Filed With SEC on May 11, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2020)
- Prior Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2020)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on May 11, 2020)
- 2015 Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on May 11, 2020)
